Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2012
10/31/2012CN102757389A 雄激素受体拮抗剂及其用途 Androgen receptor antagonists and their use
10/31/2012CN102757385A Preparation method and application of diaryl quinoline analogue
10/31/2012CN102757296A Method for marking compound with [18F]
10/31/2012CN101845011B (S)-prolineamide type derivative, preparation method and application thereof
10/31/2012CN101675032B Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
10/31/2012CN101426782B Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
10/31/2012CN101312960B F,G,H,I and K crystal forms of imatinib mesylate
10/31/2012CN101287712B Heterocyclic compounds
10/30/2012US8299261 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
10/30/2012US8299260 Process for preparing aryl-substituted pyrazoles
10/30/2012US8299258 Method of making piperidine derivatives
10/30/2012US8299253 Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
10/30/2012US8299247 Material for organic electroluminescence device and organic electroluminescence device
10/30/2012US8299245 Method for producing pyrimidine compound
10/30/2012US8299243 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
10/30/2012US8299173 Method involving 1-benzotriazolyl carbonate esters of polymers
10/30/2012US8299110 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors
10/30/2012US8299108 Substituted benzazoles and methods of their use as inhibitors of raf kinase
10/30/2012US8299101 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators
10/30/2012US8299100 Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8299088 Compositions and methods for treating cancer
10/30/2012US8299085 Quinazoline derivatives
10/30/2012US8299082 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
10/30/2012US8299076 Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
10/30/2012US8299073 P38 MAP kinase inhibitors
10/30/2012US8299072 Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof
10/30/2012US8299067 5-demethoxyfumagillol and derivatives thereof
10/30/2012US8299065 Antibacterial condensed thiazoles
10/30/2012US8299063 Amido-thiophene compounds and their use
10/30/2012US8299055 8-substituted isoquinoline derivative and the use thereof
10/30/2012US8299048 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
10/30/2012US8298512 Methods of determining β-III tubulin expression
10/30/2012CA2682504C Aurora kinase modulators and method of use
10/30/2012CA2669695C Tetrahydropyridinyl compounds for inflammation and immune-related uses
10/30/2012CA2592869C Anthrapyridone compound, magenta ink composition and colored matter
10/30/2012CA2567484C Pyrimidine compounds and their use as modulators of the dopamine d3 receptor
10/30/2012CA2566896C Bicyclic-substituted amines having cyclic-substituted monocyclic substituents for modulating effects of histamine-3 receptor
10/30/2012CA2565293C Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
10/26/2012WO2012145604A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/26/2012WO2012145603A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/26/2012WO2012145569A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/26/2012WO2012143726A1 Bicyclic heterocycle compounds and their uses in therapy
10/26/2012WO2012143599A1 Androgen receptor modulating carboxamides
10/26/2012WO2012143415A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012WO2012143413A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012WO2012143399A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
10/26/2012WO2012143340A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators
10/26/2012WO2012143317A1 Novel pesticidal pyrazole compounds
10/26/2012WO2012119046A3 Heterocyclic compounds for the inhibition of pask
10/26/2012WO2012118309A3 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same
10/26/2012WO2012096934A3 Inhibitors of retroviral replication
10/26/2012CA2833288A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
10/26/2012CA2832763A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012CA2831346A1 Bicyclic heterocycle compounds and their uses in therapy
10/26/2012CA2831338A1 Androgen receptor modulating carboxamides
10/26/2012CA2830138A1 Novel pesticidal pyrazole compounds
10/26/2012CA2829264A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
10/26/2012CA2825971A1 5-(phenyl/pyridinyl-ethinyl) -2 -pyridine/ 2 -pyrimidine-carborxamides as mglur5 modulators
10/25/2012US20120270905 Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
10/25/2012US20120270898 Sulfonamide compound and crystal thereof
10/25/2012US20120270891 Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
10/25/2012US20120270885 Chemical compounds
10/25/2012US20120270882 Fluorinated derivates of 3-hydroxypyridin-4-ones
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270875 Pyrimidine amide compounds
10/25/2012US20120270865 Heterocyclic compound
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270859 Indoline derivatives and their use in treating disease-states such as cancer
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270856 Heteroaryloxy quinazoline derivatives
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120269894 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
10/25/2012US20120269724 Compositions and methods for imaging tissues, organs and tumors
10/25/2012US20120268706 Compounds and liquid-crystalline medium
10/25/2012US20120267620 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the organic photoelectric device
10/25/2012DE102012008570A1 New substituted piperidine compounds are useful in a liquid crystal medium, which is useful in an electro-optical display or electro-optical component, preferably vertical alignment or electrically controlled birefringence display
10/24/2012EP2515615A1 Method for manufacturing organic electroluminescent element, organic electroluminescent element, display device and illuminating device
10/24/2012EP2514748A1 2,4-diaminoquinazolines for spinal muscular atrophy
10/24/2012EP2513088A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/24/2012EP2513087A1 Tetrazole derivatives as nicotinic acetylcholine receptor moudlators
10/24/2012EP2513086A1 Novel antagonists for ccr2 and uses thereof
10/24/2012EP2513085A1 BICYCLIC COMPOUNDS AS alpha4beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
10/24/2012EP2513084A1 Pyrrolidine derivatives as nk - 3 receptor antagonists
10/24/2012EP2513057A1 Sphingosine kinase inhibitors
10/24/2012EP2513053A1 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2512480A1 Hepatitis c virus inhibitors
10/24/2012EP2512474A1 N-linked hydroxamic acid derivatives useful as antibacterial agents
10/24/2012EP2512243A1 Quinoline amide m1 receptor positive allosteric modulators
10/24/2012EP2512241A1 Compounds for the treatment of neurologic disorders
10/24/2012CN102753544A 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/24/2012CN102753542A Substituted benzoazepines as toll-like receptor modulators
10/24/2012CN102753541A Carboxamide compounds and their use as calpain inhibitors iv
10/24/2012CN102753540A A4ss2 neuronal nicotinic acetylcholine receptor ligands
10/24/2012CN102753535A Quinazolines as potassium ion channel inhibitors
10/24/2012CN102753533A Imidazolidinedione derivatives
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 1080